Logo image of ALB

ALBEMARLE CORP (ALB) Stock Fundamental Analysis

USA - NYSE:ALB - US0126531013 - Common Stock

96.5 USD
+4.81 (+5.25%)
Last: 10/9/2025, 6:54:07 PM
98.12 USD
+1.62 (+1.68%)
After Hours: 10/9/2025, 6:54:07 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ALB. ALB was compared to 83 industry peers in the Chemicals industry. The financial health of ALB is average, but there are quite some concerns on its profitability. ALB is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALB had negative earnings in the past year.
In the past year ALB had a positive cash flow from operations.
ALB had positive earnings in 4 of the past 5 years.
ALB had a positive operating cash flow in each of the past 5 years.
ALB Yearly Net Income VS EBIT VS OCF VS FCFALB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

The Return On Assets of ALB (-6.34%) is worse than 73.49% of its industry peers.
ALB's Return On Equity of -10.70% is on the low side compared to the rest of the industry. ALB is outperformed by 68.67% of its industry peers.
Industry RankSector Rank
ROA -6.34%
ROE -10.7%
ROIC N/A
ROA(3y)6.03%
ROA(5y)4.56%
ROE(3y)12.4%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
ALB Yearly ROA, ROE, ROICALB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

ALB's Gross Margin of 7.76% is on the low side compared to the rest of the industry. ALB is outperformed by 85.54% of its industry peers.
In the last couple of years the Gross Margin of ALB has declined.
ALB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.02%
GM growth 5Y-49.18%
ALB Yearly Profit, Operating, Gross MarginsALB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

4

2. Health

2.1 Basic Checks

ALB does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALB has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALB has more shares outstanding
ALB has a better debt/assets ratio than last year.
ALB Yearly Shares OutstandingALB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ALB Yearly Total Debt VS Total AssetsALB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

ALB has an Altman-Z score of 1.77. This is a bad value and indicates that ALB is not financially healthy and even has some risk of bankruptcy.
ALB has a Altman-Z score of 1.77. This is comparable to the rest of the industry: ALB outperforms 45.78% of its industry peers.
A Debt/Equity ratio of 0.31 indicates that ALB is not too dependend on debt financing.
ALB has a Debt to Equity ratio of 0.31. This is in the better half of the industry: ALB outperforms 75.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 1.77
ROIC/WACCN/A
WACC8.23%
ALB Yearly LT Debt VS Equity VS FCFALB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 2.31 indicates that ALB has no problem at all paying its short term obligations.
ALB's Current ratio of 2.31 is fine compared to the rest of the industry. ALB outperforms 62.65% of its industry peers.
ALB has a Quick Ratio of 1.47. This is a normal value and indicates that ALB is financially healthy and should not expect problems in meeting its short term obligations.
ALB has a Quick ratio of 1.47. This is in the better half of the industry: ALB outperforms 63.86% of its industry peers.
Industry RankSector Rank
Current Ratio 2.31
Quick Ratio 1.47
ALB Yearly Current Assets VS Current LiabilitesALB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

5

3. Growth

3.1 Past

The earnings per share for ALB have decreased strongly by -155.42% in the last year.
Looking at the last year, ALB shows a very negative growth in Revenue. The Revenue has decreased by -33.05% in the last year.
The Revenue has been growing by 8.42% on average over the past years. This is quite good.
EPS 1Y (TTM)-155.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
Revenue 1Y (TTM)-33.05%
Revenue growth 3Y17.35%
Revenue growth 5Y8.42%
Sales Q2Q%-7.02%

3.2 Future

The Earnings Per Share is expected to grow by 63.36% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALB will show a quite strong growth in Revenue. The Revenue will grow by 11.24% on average per year.
EPS Next Y31.2%
EPS Next 2Y47.08%
EPS Next 3Y60.09%
EPS Next 5Y63.36%
Revenue Next Year-9.72%
Revenue Next 2Y-1.49%
Revenue Next 3Y3.9%
Revenue Next 5Y11.24%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALB Yearly Revenue VS EstimatesALB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
ALB Yearly EPS VS EstimatesALB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 20 30

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ALB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 252.55, the valuation of ALB can be described as expensive.
Based on the Price/Forward Earnings ratio, ALB is valued a bit more expensive than the industry average as 68.67% of the companies are valued more cheaply.
ALB is valuated expensively when we compare the Price/Forward Earnings ratio to 23.15, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 252.55
ALB Price Earnings VS Forward Price EarningsALB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150 200 250

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALB indicates a slightly more expensive valuation: ALB is more expensive than 79.52% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 29.58
ALB Per share dataALB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALB does not grow enough to justify the current Price/Earnings ratio.
ALB's earnings are expected to grow with 60.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.08%
EPS Next 3Y60.09%

More info and screens

5

5. Dividend

5.1 Amount

ALB has a Yearly Dividend Yield of 1.85%. Purely for dividend investing, there may be better candidates out there.
ALB's Dividend Yield is comparable with the industry average which is at 3.61.
Compared to the average S&P500 Dividend Yield of 2.44, ALB is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.85%

5.2 History

On average, the dividend of ALB grows each year by 13.04%, which is quite nice.
ALB has paid a dividend for at least 10 years, which is a reliable track record.
ALB has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)13.04%
Div Incr Years30
Div Non Decr Years30
ALB Yearly Dividends per shareALB Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

ALB has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of ALB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-32.53%
EPS Next 2Y47.08%
EPS Next 3Y60.09%
ALB Yearly Income VS Free CF VS DividendALB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

More info and screens

ALBEMARLE CORP

NYSE:ALB (10/9/2025, 6:54:07 PM)

After market: 98.12 +1.62 (+1.68%)

96.5

+4.81 (+5.25%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners99.06%
Inst Owner Change0%
Ins Owners0.37%
Ins Owner Change3.38%
Market Cap11.36B
Analysts68.39
Price Target84.68 (-12.25%)
Short Float %13.22%
Short Ratio3.47
Dividend
Industry RankSector Rank
Dividend Yield 1.85%
Yearly Dividend2.65
Dividend Growth(5Y)13.04%
DP-32.53%
Div Incr Years30
Div Non Decr Years30
Ex-Date09-12 2025-09-12 (0.405)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)91.46%
Min EPS beat(2)69.72%
Max EPS beat(2)113.21%
EPS beat(4)2
Avg EPS beat(4)-30.22%
Min EPS beat(4)-249.28%
Max EPS beat(4)113.21%
EPS beat(8)3
Avg EPS beat(8)-20.6%
EPS beat(12)7
Avg EPS beat(12)-3.87%
EPS beat(16)11
Avg EPS beat(16)2.43%
Revenue beat(2)1
Avg Revenue beat(2)0.26%
Min Revenue beat(2)-7.88%
Max Revenue beat(2)8.39%
Revenue beat(4)1
Avg Revenue beat(4)-2.61%
Min Revenue beat(4)-8.69%
Max Revenue beat(4)8.39%
Revenue beat(8)4
Avg Revenue beat(8)-0.47%
Revenue beat(12)4
Avg Revenue beat(12)-1.94%
Revenue beat(16)6
Avg Revenue beat(16)-0.69%
PT rev (1m)3.57%
PT rev (3m)6.42%
EPS NQ rev (1m)-0.07%
EPS NQ rev (3m)-93.45%
EPS NY rev (1m)2.55%
EPS NY rev (3m)-2.56%
Revenue NQ rev (1m)0.16%
Revenue NQ rev (3m)0.31%
Revenue NY rev (1m)0.24%
Revenue NY rev (3m)1.71%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 252.55
P/S 2.27
P/FCF N/A
P/OCF 14.57
P/B 1.11
P/tB 1.36
EV/EBITDA 29.58
EPS(TTM)-2.71
EYN/A
EPS(NY)0.38
Fwd EY0.4%
FCF(TTM)-1.54
FCFYN/A
OCF(TTM)6.62
OCFY6.86%
SpS42.43
BVpS87.02
TBVpS70.82
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.34%
ROE -10.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.76%
FCFM N/A
ROA(3y)6.03%
ROA(5y)4.56%
ROE(3y)12.4%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.02%
GM growth 5Y-49.18%
F-Score4
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA 7.46
Cap/Depr 146.27%
Cap/Sales 19.25%
Interest Coverage N/A
Cash Conversion 182.86%
Profit Quality N/A
Current Ratio 2.31
Quick Ratio 1.47
Altman-Z 1.77
F-Score4
WACC8.23%
ROIC/WACCN/A
Cap/Depr(3y)401.9%
Cap/Depr(5y)389.55%
Cap/Sales(3y)23.64%
Cap/Sales(5y)25.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-155.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
EPS Next Y31.2%
EPS Next 2Y47.08%
EPS Next 3Y60.09%
EPS Next 5Y63.36%
Revenue 1Y (TTM)-33.05%
Revenue growth 3Y17.35%
Revenue growth 5Y8.42%
Sales Q2Q%-7.02%
Revenue Next Year-9.72%
Revenue Next 2Y-1.49%
Revenue Next 3Y3.9%
Revenue Next 5Y11.24%
EBIT growth 1Y79.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year159.37%
EBIT Next 3Y44.89%
EBIT Next 5Y36.66%
FCF growth 1Y-118.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-70.5%
OCF growth 3Y26.81%
OCF growth 5Y-0.49%